0001209191-23-044284.txt : 20230802 0001209191-23-044284.hdr.sgml : 20230802 20230802180010 ACCESSION NUMBER: 0001209191-23-044284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRYSKA DAVID W CENTRAL INDEX KEY: 0001202335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 231137326 MAIL ADDRESS: STREET 1: 749 N MARY AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forte Biosciences, Inc. CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3060 PEGASUS PARK DRIVE STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: (310) 618-6994 MAIL ADDRESS: STREET 1: 3060 PEGASUS PARK DRIVE STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 FORMER COMPANY: FORMER CONFORMED NAME: Tocagen Inc DATE OF NAME CHANGE: 20071120 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-31 0 0001419041 Forte Biosciences, Inc. FBRX 0001202335 GRYSKA DAVID W C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BUILDING 6 DALLAS TX 75247 1 0 0 0 0 Common Stock 2023-07-31 4 A 0 148514 1.01 A 148514 D /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact 2023-08-02